The treatment of patients suffering from chronic autoimmune diseases such as RA has been revolutionized over the past two decades by the development and approval of disease modifying anti-TNF biologics which have changed the clinical outcome for millions of patients and has validated TNF as an important therapeutic target. Here, TNF is linked to rheumatoid arthritis.